ChromaDex, Inc. to Present Strategic Plan for Growth at Accredited Members Summer 2011 Small Cap/Micro Cap Investment Conference

IRVINE, Calif., June 6, 2011 /PRNewswire/ --ChromaDex Corporation (OTCBB: CDXC) announced today that its President William F. Spengler will be presenting the company's business strategy and growth opportunities at the Accredited Members investment conference on Tuesday, June 14th. The company's presentation will be made available to the public on the company's website, www.chromadex.com, on that same day.

Mr. Spengler's presentation takes place at the Accredited Members Summer 2011 Small Cap/Micro Cap Investment Research conference at the Hyatt Regency Denver Tech Center in Denver, Colorado. For further details please visit their website at http://www.accreditedmembers.com/conference.

For more information, visit www.chromadex.com and www.pteropure.com.

About ChromaDex

ChromaDexis an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure® pterostilbene for which it has worldwide, exclusive patent rights.

ChromaDex Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

ChromaDex Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
John@Liviakis.com

ChromaDex Contact
Laura Carney
Administrative Assistant
949-419-0288
laurac@chromadex.com

Media Inquiries:
Carolyn Hawley
Canale Communications
619-849-5375
carolyn@canalecomm.com

SOURCE ChromaDex Corporation

Back to news